HIV and men who have sex with men - Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
This report is part of the 2018 progress reports monitoring the implementation of the Dublin Declaration. It presents the situation among men who have sex with men (MSM), a key group affected by HIV in the WHO European Region, and outlines priorities for action.
Half of all women with HIV are diagnosed late in Europe
Many women in the WHO European Region, particularly those in their 40s, are diagnosed at a late stage of HIV infection when their immune system is already starting to fail. They are three to four times more likely to be diagnosed late than younger women. According to data for 2018 released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe, women accounted for one-third of the 141 000 new HIV diagnoses in the Region, indicating that this population needs more attention in Europe's prevention and testing efforts.
HIV testing, Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
This report presents the situation of HIV testing in Europe and Central Asia. It summarises data on implementation of national guidelines that shape HIV testing policies, the provision and uptake of HIV testing services in general and among key populations, and efforts being made to widen engagement with HIV testing and reduce late diagnosis.
Know your status: get tested during European Testing Week
On the way towards the Sustainable Development Goal (SDG) for health, Europe has one important battle to take on: reducing the proportion of those living with undiagnosed HIV and viral hepatitis. Current status in the EU/EEA: one in seven people living with HIV are unaware of their infection, up to four out of 5 people living with hepatitis B and three out of four people with hepatitis C infection have not yet been diagnosed.
Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
The benefits of HIV treatment: undetectable means you do not pass on the virus
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
Implementing and expanding HIV testing in immigrant populations in Europe: Comparing guideline's recommendations and expert's opinions [Implementación y expansión de la prueba de VIH en población inmigrante en Europa: confrontación de las recomendaciones
Álvarez-del Arco, D., Monge, S., Rivero-Montesdeoca, Y., Burns, F., Noori, T., del Amo, J.
Late presentation to HIV testing is overestimated when based on the consensus definition
Sasse, A., Florence, E., Pharris, A., De Wit, S., Lacor, P., Van Beckhoven, D., Deblonde, J., Delforge, M.-L., Fransen, K., Goffard, J.-C., Legrand, J.-C., Moutschen, M., Piérard, D., Ruelle, J., Vaira, D., Vandercam, B., Van Ranst, M., Van Wijngaerden, E., Vandekerckhove, L., Verhofstede, C.